Nebraska Heme Onc — Lincoln, Nebraska

Nebraska Heme Onc is a clinical research site located in Lincoln, Nebraska, United States 68506.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Nebraska Heme Onc has participated in 1 clinical trials.

Therapeutic areas: Gastric Cancer, Gastroesophageal Junction Cancer, HER2-positive Gastric Cancer.

Sponsors: MacroGenics.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nebraska Heme Onc?

Nebraska Heme Onc has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nebraska Heme Onc conducted?

Nebraska Heme Onc has 1 clinical trials on record. Their work covers Gastric Cancer, Gastroesophageal Junction Cancer, HER2-positive Gastric Cancer.

Is Nebraska Heme Onc accredited by Crixeo Health?

Nebraska Heme Onc has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Nebraska Heme Onc?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.